Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 13Active not recruiting 5Recruiting 4Terminated 3Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 3Carcinoma, Non-Small-Cell Lung 3Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uveal Melanoma 1Turcot syndrome 1Sarcoma 1Post-Acute COVID-19 Syndrome 1Pancreatic Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Clear-cell metastatic renal cell carcinoma 1Carcinoma 1Advanced Kidney Cancer 1

Interventions

Gemcitabine 21130-nm albumin-bound paclitaxel 8irinotecan sucrosofate 7Oxaliplatin 7Leucovorin 7Fluorouracil 7Taxes 5Drug Therapy 5Albumin-Bound Paclitaxel 4toripalimab 3Specimen Handling 3S 1 (combination) 3Paclitaxel 3Irinotecan 3Injections 3zimberelimab 2surufatinib 2camrelizumab 2Pemetrexed 2Pancreaticoduodenectomy 2Magnetic Resonance Spectroscopy 2Exercise 2Capecitabine 2Blood Specimen Collection 2Biopsy 2trastuzumab deruxtecan 1sintilimab 1semaglutide 1potassium oxonate 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic Neoplasms × Ipilimumab × Clear all
NCT07587827 2026-05-14

ODI-2001-01

Centre Georges Francois Leclerc

Phase 1 Not yet recruiting
77 enrolled
Gastrointestinal

Pancreatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡